Aran, A. (2018). Cannabinoids for Behavioral Problems in Children With ASD (CBA). Jerusalem, Israel: Shaare Zedek Medical Center, 2 p. Clinical study in progress. Expected end 2019.

Aran, A.; Cassuto, H.; Lubotzky, A. (2018) Cannabidiol Based Medical Cannabis in Children with Autism: a Retrospective Feasibility Study. Neurology. American Academy Of Neurology, abr. p. 3-318.

Autism Society of América - ASA. (1999). Autism. Departament of Health ando Human Services. Public Health Service National Institutes of Health. U.S.

Associação Americana De Psiquiatria -APA. (2013). Diagnostic and Statistical Manual of Mental Disorder - DSM-V, 5 ed. 

Bailey, A.; Couter, A. Le; Gottesman, L. (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med, [s.l], v. 25, p.63-77.

Bellinger, D. C. (2012). Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factors. Neurotoxicology, [s.l.], v. 33, n. 4, p.641-643, ago.

Bianchini, N. C. P.; De Paula Souza, L. A. (2014). Autismo e comorbidades: achados atuais e futuras direções de pesquisa. Distúrbios da Comunicação, [s.l], v. 26, n. 3, p.624-626, set.

Brasil. (1996). Lei de Diretrizes e Bases da Educação Nacional nº 9394, de 20 de dezembro de 1996. Lei de Diretrizes e Bases da Educação Nacional. Brasília, DF: Ministério da Educação, 20 dez. 

Brasil. (2012). Lei nº 12.764, de 27 de dezembro de 2012. Lei Nº 12.764, de 27 de dezembro de 2012. Brasília, DF: Presidência da República, 27 dez. Institui a Política Nacional de Proteção dos Direitos da Pessoa com Transtorno do Espectro Autista; e altera o § 3o do art. 98 da Lei no 8.112, de 11 de dezembro de 1990.

Brasil. (2017). Lei nº 13.438, de 26 de abril de 2017. Lei Nº 13.438, de 26 de abril de 2017. Brasília, DF: Presidência da República, 26 abr.

Brasil. (1993). Lei Orgânica nº 8.742, de 07 de dezembro de 1993. Lei Orgânica da Assistência Social (loas). Brasília, DF, 07 dez. 

Brasil. (2008). Portaria nº Portaria nº 948/2007, de 07 de janeiro de 2008. Política Nacional de Educação Especial na Perspectiva da Educação Inclusiva. Brasília, DF, 07 Jan. 

Buescher, A. V. S. et al. (2014). Costs of Autism Spectrum Disorders in the United Kingdom and the United States. Jama Pediatrics, [s.l.], v. 168, n. 8, p.721-728, 1 ago. 

Ciaranello, A. L.; Ciaranello, R. D. (1995). The neurobiology of infantile autism. Ann. Rev. Neurosc, [s.l], v. 18, p.101-128.

Fischer, B. et al. (2015). Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use. International Journal of Drug Policy, [s.l.], v. 26, n. 12, p.1177-1182, dez. 

Gauderer, E. C. (1985). Autismo, década de 80: uma atualização para os que atuam na área do especialista aos pais. São Paulo: Sarvier.

Geier, D. et al. (2013). A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Translational Neurodegeneration, [s.l.], v. 2, n. 1, p.1-12. 

Gillberg, C. (1988). The neurobiology of infantile autism. J. Child. Psychol. Psychiatry, [s.l], v. 29, p.257-266.

Gontijo, E. C. et al. (2016). Canabidiol e suas aplicações terapêuticas. Refacer - Revista Eletrônica da Faculdade de Ceres, Goiás, v. 15, n. 1, p.1-9, jan.

Grandjean, P.; Landrigan, P. J. (2014). Neurobehavioral effects of developmental toxicity. The Lancet Neurology, [s.l.], v. 13, n. 3, p.330-338, mar. 

Hadjkacem, I. et al. (2016). Prenatal, perinatal and postnatal factors associated with autism spectrum disorder. Jornal de Pediatria, [s.l.], v. 92, n. 6, p.595-601, nov. 

Holingue, C. et al. (2017). Gastrointestinal symptoms in autism spectrum disorder: A review of the literature on ascertainment and prevalence. Autism Research, [s.l.], v. 11, n. 1, p.24-36, 30 ago.

Hussain, S. A. et al. (2015). Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome. Epilepsy & Behavior, [s.l.], v. 47, p.138-141, jun.

Järbrink, K. (2007). The economic consequences of autistic spectrum disorder among children in a Swedish municipality. Autism, [s.l.], v. 11, n. 5, p.453-463, set. 

Kanner, L. (1943). Autisc Disturbances of Affective Contact. Nervous Child., [s.l.], v. 2, p.217-250.

Kaplan, J. S. et al. (2017). Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proceedings of the National Academy of Sciences, [s.l.], v. 114, n. 42, p.11229-11234, 2 out. 

Lampreia, C. (2004). Os enfoques cognitivista e desenvolvimentista no autismo: uma análise preliminar. Psicologia: Reflexão e Crítica, [s.l.], v. 17, n. 1, p.111-120. 

Malcher-Lopes, R. (2014). Canabinoides ajudam a desvendar aspectos etiológicos em comum e trazem esperança para o tratamento de autismo e epilepsia. Revista da Biologia, [s.l.], v. 13, n. 1, p.43-59, dez. 

Martino, D.; Ganos, C.; Pringsheim, T. M. (2017). Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics. International Review of Neurobiology, [s.l.], p.1461-1490. 

Mohamed, F. E. B. et al. (2015). Assessment of Hair Aluminum, Lead, and Mercury in a Sample of Autistic Egyptian Children: Environmental Risk Factors of Heavy Metals in Autism. Behavioural Neurology, [s.l.], v. 2015, p.1-9. 

Nunes, M.; Bruni, O. (2015). Insomnia in childhood and adolescence: clinical aspects, diagnosis, and therapeutic approach. Jornal de Pediatria, [s.l.], v. 91, n. 6, p.26-35, nov. 

Organização Mundial de Saúde - OMS. (1993). Classificação de Transtornos Mentais e de Comportamentos: Descrições Clínicas e Diretrizes Diagnósticas. 10. ed. Porto Alegre: Artes Médicas.

Orrú, S. E. (2016). Aprendizes com autismo: aprendizagem por eixos de interesse em espaços não excludentes. Rio de Janeiro: Vozes.

Press, C. A.; Knupp, K. G.; Chapman, K. E. (2015). Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & Behavior, [s.l.], v. 45, p.49-52, abr. 

Rapin, I. (1991). Autistic children: diagnosis and clinical features. Pediatrics: (supl.), [s.l], v. 87, p.751-760.

Ritvo, E. R. (1976). Autism: diagnosis, current research and management. New York: Spectrum.

Russo, F. B. et al. (2018). Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells. Biological Psychiatry, [s.l.], v. 83, n. 7, p.569-578, abr. 

Rutter, M.; Schopler, E. (1992). Classification of pervasive developmental disorders: some concepts and practical considerations. J. Autism Dev. Disord., [s.l], v. 22, p.459-482.

Rutter, M.; Shopler, E. (1988). Autism and pervasive developmental disorders: Concepts and diagnostic issues. In: Schopler, E.; Mesibov, G. B. Diagnosis and assessment in autism. New York: Plenum Press, p. 15-36.

Sacks, O. W. (1995). Um antropólogo em Marte. São Paulo: Companhia das Letras.

Sanders, A. P.; Henn, B. C.; Wright, R. O. (2015). Perinatal and Childhood Exposure to Cadmium, Manganese, and Metal Mixtures and Effects on Cognition and Behavior: A Review of Recent Literature. Current Environmental Health Reports, [s.l.], v. 2, n. 3, p.284-294, 5 Jul.

Schreck, K.(2004). Sleep problems as possible predictors of intensified symptoms of autism*1. Research In Developmental Disabilities, [s.l.], v. 25, n. 1, p.57-66, fev. 

Sellin, B. (1993). Une âme prisonnière. Paris: Réponses/Robert Laffont.

Stessman, H. A. F. et al. (2017). Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nature Genetics, [s.l.], v. 49, n. 4, p.515-526, 13 fev. 

Steiner, C. E. (2002). Transtornos Globais do Desenvolvimento: caracterização genético-clínica e neurológica de uma amostra de indivíduos da região de Campinas, SP. Tese de Doutorado. Unicamp: Campinas.

United Nations Organization - ONU. (2017). UN calls for recognizing the rights of people with autism to make their own decisions. United Nations Organization. Usa, p. 1-2. 31 mar. 2017. Disponível em: Acesso em: 17 maio 2018.

WING, L.; Gould, J. (1979). Severe impairments of social interaction and associated abnormalities in children: Epidemiology and classification. Journal Of Autism And Developmental Disorders, [s.l.], v. 9, n. 1, p.11-29, mar. 

Yang, X. et al. (2018). Are gastrointestinal and sleep problems associated with behavioral symptoms of autism spectrum disorder? Psychiatry Research, [s.l.], v. 259, p.229-235, Jan. 

Zanolla, T. A. et al. (2015). Causas genéticas, epigenéticas e ambientais do transtorno do espectro autista. Cadernos de Pós-graduação em Distúrbios do Desenvolvimento, São Paulo, v. 15, n. 2, p.29-42.